![Cybin logo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>)
May 2026
📣 VC round data is live. Check it out!
Largest Digital Therapeutics Public Companies
Benchmark revenue and EBITDA valuation multiples for public comps like
Alignment Healthcare, Sphere, Compass Pathways, Cybin and AMJ Global Technology.
 | Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes. | $18 | +17% | $4B | $3B | 0.8x | 30.1x | ||
 | Sphere Corp Formerly Life Semantics Corp is engaged in the development and supply of innovative healthcare solutions such as providing a technology platform for digital transformation in the healthcare field and non-face-to-face medical and digital treatment devices. | $29 | +349% | $1B | $1B | 20.5x | 214.7x | ||
 | Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360. | $10 | +138% | $1B | $1B | — | (6.9x) | ||
-- | — | -- | -- | $330M | $275M | — | — | ||
| AMJ Global Technology is a USA-based company which is focusing on the intersection of technology and wholistic technology-based health treatments, with the intention to provide services to formulate a treatment model to meet the needs of professional athletes that suffer from PTSD and the early onset of dementia and Alzheimer’s. The Company is currently evaluating operations in the wholistic health industry. The Company has not generated any revenue. | $1 | +30% | $141M | $141M | 3626831.2x | (769.5x) | ||
 | Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke. | $3 | -60% | $139M | $130M | 11.1x | (1.5x) | ||
| Oneview Healthcare PLC provides patient engagement and clinical workflow technology solutions to healthcare facilities. It serves hospitals and healthcare systems, academic medical centers, and pediatric hospitals. Oneview Healthcare’s Care Experience Platform (CXP) provides a unified set of digital tools in a single bedside solution and connects patients, families, and care teams with services, education, and information during hospital stays. | $0 | -37% | $105M | $101M | 7.1x | (9.1x) | ||
| Kooth PLC is a digital mental health provider to the NHS for children and young people by providing a broad range of therapeutic tools and interventions. The company's online platform provides Self-help tools and content, Community for Peer-to-Peer Support and Professional Counselling. It provides individuals with free access to mental health support, funded by healthcare systems, insurers, businesses or charities. The company's operations take place in the UK and the United States. | $2 | -22% | $66M | $37M | 0.4x | 1.9x | ||
| DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. | $8 | -45% | $57M | $63M | 2.8x | (2.6x) | ||
 | Welby Inc offers patients and their families digital tools helping medical treatment and prevention of the progression of disease. The company co-develops and co-provides digital services with pharmaceuticals, medical device companies, governments, along with patients and healthcare professionals. | $2 | -13% | $16M | $16M | 3.8x | (4.9x) | ||
| Physitrack PLC is a digital healthcare provider, focused on physiotherapy and musculoskeletal care market. The company operates in two business lines namely Lifecare and Wellness. The Lifecare segment is the provision of Lifecare platforms tailored to physiotherapy being made up of the Physitrack PLC, Physiotools OY and Mobilus Digital Rehab AB Physiotools businesses. The Wellness segment relates to the provision of Wellness services including digital platforms to both corporates and individuals. Geographically, the company has its presence in United Kingdom, Europe, North America and Rest of World. | $1 | -37% | $14M | $18M | 1.0x | (7.6x) | ||
 | Brain+ AS is a digital therapeutics company. It is focused on developing and commercializing solutions for dementia care and with a primary focus on Cognitive Stimulation Therapy (CST). The company has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI). The company is developing Ayla, a scalable dementia care platform that provides software-based therapy and care solutions designed to support individuals with dementia. | $0 | -86% | $461K | ($219K) | — | — | ||
| Median | $2 | -22% | $122M | $115M | 3.8x | (3.8x) |
Financial data powered by FactSet and Morningstar. Valuation multiples as of current fiscal year. For more data, start your free trial here.
Recent Insights
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.